Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K192406
    Manufacturer
    Date Cleared
    2020-11-25

    (448 days)

    Product Code
    Regulation Number
    878.4400
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K143203, K070356

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The AveCure BT Microwave Ablation System is intended for:

    • Palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body.
    • · Coagulation and ablation of tissue in bone during surgical procedures, including palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard therapy.
    Device Description

    The MedWaves' AveCure BT Microwave Ablation System is comprised of a microwave (915MHz ±13MHz) generator-controller, two antenna sizes mounted on the distal end of probes or catheters of various lengths, and flexibility, and a set of extension cables, one for microwave (MW) transmission and another for information communication between the antenna and the generator. The accessories (probes, catheters and extension-cable set) are supplied sterile and the generator-controller is the durable component of the system and is supplied non-sterile.

    AI/ML Overview

    The MedWaves AveCure BT Microwave Ablation System is intended for palliative treatment of metastatic malignant lesions in a vertebral body and coagulation/ablation of tissue in bone during surgical procedures, including palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard therapy.

    Here's an analysis of the acceptance criteria and study proving the device meets them:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are not explicitly stated as distinct "criteria" with pass/fail thresholds in the provided document. Instead, the study aims to demonstrate substantial equivalence to a predicate device. The performance metrics for this equivalence are the ablation range characteristics (volume, length, and width) and the treatment duration.

    MetricPredicate OsteoCool V-3 RFA PerformanceSubject AveCure BT MWA PerformanceDifferenceEquivalence Status
    Ablation Volume
    Max Volume7018 mm³ (15 minutes cycle time)7260 mm³ (7.5 minutes cycle time)3.4%Substantially Equivalent
    Min Volume320 mm³320 mm³0%Identical
    Ablation Length (Z)
    Max Length31 mm30 mm-3%Substantially Equivalent
    Min Length10 mm10 mm0%Identical
    Ablation Width (X & Y)
    Max Width22 mm22 mm0%Identical
    Min Width8 mm8 mm0%Identical

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: The document does not explicitly state the numerical sample size used for the bench testing. It refers to "Data from experimental protocols" and "Bench testing in bone."
    • Data Provenance: The study was a bench test conducted in-vitro (in bone). The country of origin of the data is not specified, but given the company's location in San Diego, California, it is presumably United States data. The study is implicitly prospective in its design, as it's a testing conducted to support a 510(k) submission.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This information is not provided in the document. Bench testing typically relies on objective measurements rather than expert human interpretation for ground truth.

    4. Adjudication Method for the Test Set

    This information is not applicable as the ground truth for ablation performance in a bench test is typically based on direct physical measurements, not human expert adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done. The study focuses on the physical ablation capabilities of the device in a bench setting, not on physician performance with or without AI assistance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This is a physical device, not an AI algorithm. Therefore, the concept of "standalone (algorithm only)" performance is not applicable. The study evaluates the device's physical performance in creating ablations.

    7. The Type of Ground Truth Used

    The ground truth used for the bench testing was based on direct physical measurements of the ablation dimensions (volume, length, and width) created by the device in bone. The document states "Volumes are estimates based on the calculation of volume for an ellipsoid," indicating a quantitative measurement approach to define the ablation zones.

    8. The Sample Size for the Training Set

    This device is not an AI/ML algorithm that requires a training set. Therefore, this information is not applicable.

    9. How the Ground Truth for the Training Set Was Established

    As this is not an AI/ML algorithm, the concept of a training set and its ground truth is not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1